3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 2
1
Status
Completed
7
Terminated
3
Recruiting
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Interventional
3
Sponsor
Cancer Type
Classical hematology
3
Gastrointestinal
1
Conditions
Venous Thromboembolism
5
Venous Thrombosis
4
Neoplasms
4
Pulmonary Embolism
3
Thrombosis
1
Thromboembolism
1
Pancreatic Neoplasms
1
Obesity
1
Multiple Myeloma
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Interventions
Dalteparin
3
abelacimab
2
MAA868
2
perflutren
1
apixaban
1
Tinzaparin
1
Sulfur Hexafluoride
1
Heparin, Low-Molecular-Weight
1
Enoxaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Terminated
×
Pulmonary Embolism
×
Dalteparin
×
Clear all
NCT05171075
2026-04-17
MAGNOLIA
Anthos Therapeutics, Inc.
Phase 3
Terminated
417 enrolled
NCT01817257
2018-10-29
ALICAT
Cardiff University
Phase 2
Terminated
2 enrolled
NCT00876915
2015-11-24
PHACS
University of Rochester
Phase 3
Terminated
218 enrolled
20 charts